ONESOURCE SPECIALTY PHARMA
Quarterly Results Analysis [Mar2025]
ONESOURCE SPECIALTY PHARMA Quarterly Results
Standalone | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
---|---|---|---|---|---|---|
Revenues | ₹477 Cr | ₹337 Cr | ₹68 Cr | ₹73 Cr | ₹56 Cr | ₹34 Cr |
Expenses | ₹240 Cr | ₹236 Cr | ₹68 Cr | ₹76 Cr | ₹67 Cr | ₹72 Cr |
Operating Income | ₹237 Cr | ₹100 Cr | ₹0 Cr | ₹-3 Cr | ₹-10 Cr | ₹-38 Cr |
Other Income | ₹4 Cr | ₹5 Cr | ₹1 Cr | ₹3 Cr | ₹1 Cr | ₹0 Cr |
Interest | ₹32 Cr | ₹44 Cr | ₹21 Cr | ₹20 Cr | ₹26 Cr | ₹25 Cr |
Depreciation | ₹34 Cr | ₹34 Cr | ₹19 Cr | ₹20 Cr | ₹20 Cr | ₹18 Cr |
Profit Before Tax | ₹175 Cr | ₹-73 Cr | ₹-40 Cr | ₹-40 Cr | ₹-161 Cr | ₹-87 Cr |
Profit After Tax | ₹175 Cr | ₹-73 Cr | ₹-40 Cr | ₹-40 Cr | ₹-161 Cr | ₹-87 Cr |
EPS | ₹15.28 | ₹-6.38 | ₹-9.63 | ₹-9.98 | ₹-40.06 | ₹-21.61 |
Industry Peers & Returns | 1W | 1M | 1Y |
ONESOURCE SPECIALTY PHARMA | -1.1% | 0.1% | NA |
SUN PHARMACEUTICAL INDUSTRIES | -0.4% | -0.9% | 4.8% |
DIVIS LABORATORIES | -0.7% | 1.6% | 50.2% |
CIPLA | -1.7% | -1.1% | -2.3% |
TORRENT PHARMACEUTICALS | -1.1% | 1.6% | 13.7% |
DR REDDYS LABORATORIES | -4.3% | -8% | -4.4% |
MANKIND PHARMA | 6.8% | 8% | 20.9% |
ZYDUS LIFESCIENCES | -1.9% | 0.1% | -16.5% |
LUPIN | -4.3% | -6.4% | 4.6% |
ONESOURCE SPECIALTY PHARMA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 41.77 % |
Y-o-Y | 749.42 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹477 Cr | 41.77 | |
Dec2024 | ₹337 Cr | 395.36 | |
Sep2024 | ₹68 Cr | -7.06 | |
Mar2024 | ₹73 Cr | 30.14 | |
Dec2023 | ₹56 Cr | 66.72 | |
Sep2023 | ₹34 Cr | - |
ONESOURCE SPECIALTY PHARMA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 136.06 % |
Y-o-Y | Positive |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹237 Cr | 136.06 | |
Dec2024 | ₹100 Cr | 81,508.94 | |
Sep2024 | ₹0 Cr | Positive | |
Mar2024 | ₹-3 Cr | Negative | |
Dec2023 | ₹-10 Cr | Negative | |
Sep2023 | ₹-38 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 66.49 % |
Y-o-Y | Positive |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 49.63% | 66.49 | |
Dec2024 | 29.81% | 16,461.11 | |
Sep2024 | 0.18% | Positive | |
Mar2024 | -3.65% | Negative | |
Dec2023 | -18.4% | Negative | |
Sep2023 | -113.29% | - |
ONESOURCE SPECIALTY PHARMA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹175 Cr | Positive | |
Dec2024 | ₹-73 Cr | Negative | |
Sep2024 | ₹-40 Cr | Negative | |
Mar2024 | ₹-40 Cr | Negative | |
Dec2023 | ₹-161 Cr | Negative | |
Sep2023 | ₹-87 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 36.63 % | Positive | |
Dec2024 | -21.68 % | Negative | |
Sep2024 | -58.87 % | Negative | |
Mar2024 | -54.7 % | Negative | |
Dec2023 | -285.78 % | Negative | |
Sep2023 | -257.06 % | - |
ONESOURCE SPECIALTY PHARMA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Positive |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹15.28 | Positive | |
Dec2024 | ₹-6.38 | Negative | |
Sep2024 | ₹-9.63 | Negative | |
Mar2024 | ₹-9.98 | Negative | |
Dec2023 | ₹-40.06 | Negative | |
Sep2023 | ₹-21.61 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD